IP Verse

Pharmaceutical Dosage Form For Immediate Release Of An Indolinone Derivative - EP2313087

The patent EP2313087 was granted to Boehringer Ingelheim on Nov 22, 2023. The application was originally filed on Jun 4, 2009 under application number EP09757601A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2313087

BOEHRINGER INGELHEIM
Application Number
EP09757601A
Filing Date
Jun 4, 2009
Status
Patent Maintained As Amended
Oct 20, 2023
Grant Date
Nov 22, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

GENERICS UKAug 20, 2019TER MEER STEINMEISTER & PARTNERADMISSIBLE
TER MEER STEINMEISTER & PARTNER PATENTANWALTE MBBAug 20, 2019TER MEER STEINMEISTER & PARTNERADMISSIBLE
TEVA PHARMACEUTICALSAug 20, 2019LEDERER & KELLERADMISSIBLE
TEVA PHARMACEUTICALSAug 20, 2019LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBBADMISSIBLE

Patent Citations (17) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
EXAMINATIONWO2009147212
EXAMINATIONWO2009147218
EXAMINATIONWO2010081817
EXAMINATIONWO2010103058
EXAMINATIONWO2010130757
INTERNATIONAL-SEARCH-REPORTWO2004013099
INTERNATIONAL-SEARCH-REPORTWO2004096224
INTERNATIONAL-SEARCH-REPORTWO2006018182
INTERNATIONAL-SEARCH-REPORTWO2006067165
INTERNATIONAL-SEARCH-REPORTWO2007054551
OPPOSITIONUS2004176392
OPPOSITIONUS4829057
OPPOSITIONUS5916591
OPPOSITIONUS6762180
OPPOSITIONWO2004013099
OPPOSITIONWO2007054551
OPPOSITIONWO2009147212

Non-Patent Literature (NPL) Citations (12) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- Anonymous, "CHMP Assessment report - Ofev", European Medicines Agency, (20141120), pages 1 - 16, XP055636228-
OPPOSITION- Gennadios, "Chapter 16 - Soft Gelatin Capsules", Protein based films and coatings, (20020000), pages 393 - 443, XP055636270-
OPPOSITION- GENNADIOS, "Chapter 16 - Soft Gelatin Capsules"", Protein based films and coatings, (20020000), pages 393 - 443, XP055636270-
OPPOSITION- L. LACHMAN, "The Theory and Practice of Industrial Pharmacy", The Theory and Practice of Industrial Pharmacy, (19860000), pages 398 - 412, XP055636210-
OPPOSITION- M. E. AULTON, "Physicochemical principles of pharmaceuticals", Pharmaceutics - The science of dosage form design, Churchill Livingstone, (19980000), pages 18 - 36, XP055636205-
OPPOSITION- R. C. ROWE, "Lecithin", Handbook of pharmaceutical excipients, Pharmaceutical Press, (20060000), pages 409 - 411, XP055636223-
OPPOSITION- R. VOIGT, "Chapter 5 and Chapter 11", Pharmazeutische Technologie, (20060000), pages 158 - 166 ; 317-320, XP055636245-
OPPOSITION- R. VOIGT, "Chapter 5 and Chapter 11", Pharmazeutische Technologie, Stuttgart, (20060000), pages 158 - 166, 317-320, XP055636245-
OPPOSITION- SUCKER et al., "ubersicht uber wichtige hilfsstoffe", Pharmazeutische Technologie, Stuttgart, (19910000), pages 201 - 206, XP055532053-
OPPOSITION- SUCKER et al., "ÃœBERSICHT ÃœBER WICHTIGE HILFSSTOFFE", Pharmazeutische Technologie, Stuttgart, (19910000), pages 201 - 206, XP055532053-
OPPOSITION- W. FAHRIG, U et al., Die Kapsel - Grundlage, Technologie und Biopharmazie einer modernen Arzneiform, (19830000), pages 60 - 63, XP055636214-
OPPOSITION- DAVID J HAUSS, "Oral lipid-based formulations", Drugs and pharmaceutical sciences, (20070000), vol. 170, page 88, XP022211986

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents